More than one in 10 cases of multiple sclerosis (MS) begin after age 50, with more rapid progression to disability and less exposure to and benefit from disease-modifying therapies (DMTs), new data ...

AI-derived phenotypic signals from pre-diagnosis codes, labs, and medications stratified risk across rapid fibrosis progression, long-term complications, and top-decile health care costs. Hematologic ...